A combination of ginsenoside Rh2 or aPPD and docetaxel exerts synergistic activities in prostate cancer cells
Prostate cancer is the most common cancer in Canadian men, and about one in seven men is diagnosed with the disease in their lifetime. Despite huge investment into prostate cancer research, there is still no...